Cart 27 Product Products 10 204,02 € (empty)
No products
To be determined Shipping
10 204,02 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 27 items in your cart. There is 1 item in your cart.
Total products (tax excl.) 10 204,02 €
Total shipping (tax excl.) To be determined
Total (tax excl.) 10 204,02 €
Data sheet of NGFR monoclonal antibody, clone ME20.4 (FITC)
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Cat,Dog,Human,Pig,Rabbit,Sheep |
| Host species | Mouse |
| Applications | IHC,IF,Flow Cyt |
More info about NGFR monoclonal antibody, clone ME20.4 (FITC)
| Brand: | Abnova |
| Reference: | MAB5598 |
| Product name: | NGFR monoclonal antibody, clone ME20.4 (FITC) |
| Product description: | Mouse (P75 knock-out) monoclonal antibody raised against native NGFR. |
| Clone: | ME20.4 |
| Isotype: | IgG |
| Gene id: | 4804 |
| Gene name: | NGFR |
| Gene alias: | CD271|Gp80-LNGFR|TNFRSF16|p75(NTR)|p75NTR |
| Gene description: | nerve growth factor receptor (TNFR superfamily, member 16) |
| Immunogen: | Native purified NGFR from human WM245 melanoma cells. |
| Form: | Liquid |
| Recommend dilutions: | Immunohistochemistry (2 ug/mL) Flow Cytometry (20 ug/mL) ELISA (1:5000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In 10 mM Tris, 50 mM NaCl |
| Storage instruction: | Store at 4°C. |
| Conjugate tag: | FITC |
| Product type: | Primary antibodies |
| Host species: | Mouse |
| Antigen species / target species: | Human |
| Specificity: | This antibody recognizes p75NTR (low affinity neurotrophin receptor). |
| Reactivity: | Cat,Dog,Human,Pig,Rabbit,Sheep |
| Applications: | IHC,IF,Flow Cyt |
| Shipping condition: | Blue Ice |
| Publications: | Inhibition within the nucleus tractus solitarius (NTS) ameliorates environmental exploration deficits due to cerebellum lesions in an animal model for autism.Walker BR, Diefenbach KS, Parikh TN. Behav Brain Res. 2007 Jan 10;176(1):109-20. Epub 2006 Sep 12. |